SAFETY, TOLERABILITY AND BIOEQUIVALENCE ASSESSMENT OF A DISPERSIBLE TABLET FORMULATION OF PYRAZINAMIDE. International Journal of Pharmaceutical Sciences and Drug Research, [S. l.], v. 9, n. 5, p. 220–223, 2017. DOI: 10.25004/IJPSDR.2017.090503. Disponível em: https://ijpsdronline.com/index.php/journal/article/view/561.. Acesso em: 24 oct. 2025.